In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus
In Vivo Formation of 8-Iso-Prostaglandin F2α and Platelet Activation in Diabetes Mellitus
复制标题
DOI:
10.1161/01.cir.99.2.224
复制
发表时间:
1999-01
期刊:
影响因子:
37.8
通讯作者:
G. Davı̀;G. Ciabattoni;A. Consoli;A. Mezzetti;A. Falco;S. Santarone;E. Pennese;E. Vitacolonna;T. Bucciarelli;F. Costantini;F. Capani;C. Patrono
中科院分区:
文献类型:
--
作者:
G. Davı̀;G. Ciabattoni;A. Consoli;A. Mezzetti;A. Falco;S. Santarone;E. Pennese;E. Vitacolonna;T. Bucciarelli;F. Costantini;F. Capani;C. Patrono
Background—Diabetes mellitus (DM) is associated with enhanced lipid peroxidation and persistent platelet activation. We tested the hypothesis that the in vivo formation of the F2-isoprostane 8-iso-prostaglandin (PG)F2α, a bioactive product of arachidonic acid peroxidation, is enhanced in DM and contributes to platelet activation. Methods and Results—Urine samples were obtained from 85 diabetic patients and 85 age- and sex-matched healthy subjects for measurement of immunoreactive 8-iso-PGF2α and 11-dehydro-thromboxane B2 (TXM), an in vivo index of platelet activation. Sixty-two had non–insulin-dependent (NID)DM, and 23 had insulin-dependent (ID) DM. Vitamin E supplementation, metabolic control, and cyclooxygenase inhibitors were used to investigate the mechanisms of formation of 8-iso-PGF2α in this setting. Urinary 8-iso-PGF2α excretion was significantly higher (P=0.0001) in NIDDM patients (419±208 pg/mg creatinine; range 160 to 1014) than in age-matched control subjects (208±92; 41 to 433). Urinary 8-iso...